Bausch Health to Announce First Quarter 2026 Results on April 29, 2026
Rhea-AI Summary
Bausch Health (NYSE:BHC) will release first quarter 2026 financial results after market close on Wednesday, April 29, 2026.
The company will host a live conference call and webcast at 5:00 p.m. U.S. EDT the same day; materials and a replay will be available on the Investor Relations website prior to and after the call.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – BHC
On the day this news was published, BHC gained 7.36%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
BHC was modestly positive ahead of its earnings-date news, while key peers were mixed: ALVO up 5.11% and others like HCM, INDV, SUPN and AMRX down between 0.17% and 1.22%, pointing to stock-specific rather than sector-driven dynamics.
Previous Earnings date Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 21 | Earnings date set | Neutral | -2.1% | Announced timing of Q4 and full‑year 2025 results and investor call. |
The last earnings-date announcement on Jan 21, 2026 was followed by a -2.06% move, suggesting previous mild pressure around such scheduling news.
Recent news for Bausch Health has focused on product initiatives, corporate events, and financial results. On Feb 18, 2026, the company reported Q4 2025 revenues of $2.80 billion and full‑year revenues of $10.27 billion, with 2026 revenue guidance of $10.625–$10.875 billion. An earlier item on Jan 21, 2026 simply announced the Q4 and full‑year earnings date and led to a -2.06% move. Today’s announcement continues that pattern of scheduling earnings disclosures and investor calls.
Historical Comparison
In the past six months, BHC issued one prior earnings-date release, which saw a -2.06% move. This new Q1 2026 timing notice fits that pattern of modest reactions.
Earnings communications progressed from announcing Q4/full‑year 2025 timing to releasing those results, and now to scheduling Q1 2026 results and an accompanying business update call.
Market Pulse Summary
The stock moved +7.4% in the session following this news. A strong positive reaction aligns with how scheduling earnings can focus attention on prior results and guidance, such as Q4 2025 revenues of $2.80 billion and 2026 revenue guidance of $10.625–$10.875 billion. Past earnings-date news saw a -2.06% move, so a much larger gain would represent a departure from that history. Investors could weigh whether enthusiasm reflects confidence in upcoming Q1 details or short-term positioning.
AI-generated analysis. Not financial advice.
Conference Call Details
Date: Wednesday, April 29, 2026
Time: 5:00 p.m.
Webcast: http://ir.bauschhealth.com/events-and-presentations
A replay of the conference call will be available on the investor relations website.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
Investor Contact: | Media Contact: | |
Garen Sarafian | Katie Savastano | |
(877) 281-6642 (toll-free) | (908) 541-3785 | |
BHC-FINANCIAL |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-to-announce-first-quarter-2026-results-on-april-29-2026-302728610.html
SOURCE Bausch Health Companies Inc.